Literature DB >> 24247598

Prediabetes and short-term outcomes in nondiabetic patients after acute ST-elevation myocardial infarction.

Li Tian1, Jun Zhu, Lisheng Liu, Yan Liang, Jiandong Li, Yanmin Yang.   

Abstract

OBJECTIVES: A prediabetic state is defined as the time period before the development of symptomatic diabetes. Limited evidence is available for evaluating the correlation between prediabetes and short-term outcomes in nondiabetic patients with ST-elevation of myocardial infarction (STEMI).
METHODS: 4,787 nondiabetic patients with a diagnosis of STEMI based on typical onset of chest pain within 12 h were enrolled. Patients were followed up for 7 and 30 days after hospital admission. According to the 2013 Standards of Medical Care in Diabetes, the study population was stratified into three groups: normal, prediabetic and newly diagnosed diabetic patients. The primary outcomes of our study were all-cause mortality and major adverse cardiac events (MACE) on days 7 day and 30.
RESULTS: The proportions of patients with prediabetes and newly diagnosed diabetes were 31.1 and 19.2%, respectively. Rates of 7- and 30-day mortality and MACE were similar among the different HbA1c groups. Multivariable Cox regression analysis showed that compared with normal glucose metabolism, prediabetes (hazard ratio, HR, 1.003; 95% CI, 0.865-1.165) and newly diagnosed diabetes (HR, 0.887; 95% CI, 0.739-1.064) were not correlated with 30-day MACE. However, admission glucose was an independent predictor of short-term MACE (HR, 1.031; 95% CI, 1.017-1.046).
CONCLUSIONS: In nondiabetic patients after STEMI, the incidence of latent diabetes mellitus was increased. Newly diagnosed diabetes and prediabetes were not correlated with short-term outcome in nondiabetic patients with STEMI, yet admission glucose level was an independent predictor of short-term MACE. To reduce the incidence of short-term MACE after STEMI, more attention should be paid to the control of increased glucose levels and intrinsic stress states.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24247598     DOI: 10.1159/000354998

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  5 in total

1.  Conventional insulin vs insulin infusion therapy in acute coronary syndrome diabetic patients.

Authors:  Caterina Arvia; Valeria Siciliano; Kyriazoula Chatzianagnostou; Gillian Laws; Alfredo Quinones Galvan; Chiara Mammini; Sergio Berti; Sabrina Molinaro; Giorgio Iervasi
Journal:  World J Diabetes       Date:  2014-08-15

2.  Investigating microRNAs in diabetic cardiomyopathy as tools for early detection and therapeutics.

Authors:  Priyanka Mathur; Vibha Rani
Journal:  Mol Cell Biochem       Date:  2022-07-02       Impact factor: 3.396

3.  Glycosylated hemoglobin levels and clinical outcomes in nondiabetic patients with coronary artery disease: A meta-analysis.

Authors:  Jin Geng; Yanchun Zhang; Bingjian Wang; Jun Xie; Biao Xu; Ju Li
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

4.  Periodontitis as a possible early sign of diabetes mellitus.

Authors:  Wijnand J Teeuw; Madeline X F Kosho; Dennis C W Poland; Victor E A Gerdes; Bruno G Loos
Journal:  BMJ Open Diabetes Res Care       Date:  2017-01-19

5.  Screening for prediabetes using machine learning models.

Authors:  Soo Beom Choi; Won Jae Kim; Tae Keun Yoo; Jee Soo Park; Jai Won Chung; Yong-ho Lee; Eun Seok Kang; Deok Won Kim
Journal:  Comput Math Methods Med       Date:  2014-07-16       Impact factor: 2.238

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.